From Name

From Email

To Name

To Email

Message

A Promising Drug for the Treatment of Severe Lung Inflammation in COVID-19 Patients

from Albert Einstein College of Medicine via Medical Xpress

A Promising Drug for the Treatment of Severe Lung Inflammation in COVID-19 Patients Albert Einstein College of Medicine via Medical Xpress Montefiore Health System and Albert Einstein College of Medicine are the first sites in the nation to begin evaluating an investigational drug in two separate, FDA-approved trials: one to treat mild-to-moderate cases of COVID-19 and the other to treat severely ill COVID-19 patients. They are hopeful that the drug, leronlimab, may prevent the "cytokine storm" that inflames and fatally damages the lungs and other organs of many COVID-19 patients. READ MORE

more